Metropolis Healthcare (India) Performance
| METROPOLIS | 2,062 46.70 2.32% |
The company secures a Beta (Market Risk) of 0.19, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Metropolis Healthcare's returns are expected to increase less than the market. However, during the bear market, the loss of holding Metropolis Healthcare is expected to be smaller as well. At this point, Metropolis Healthcare has a negative expected return of -0.0163%. Please make sure to verify Metropolis Healthcare's maximum drawdown, accumulation distribution, as well as the relationship between the Accumulation Distribution and market facilitation index , to decide if Metropolis Healthcare performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Metropolis Healthcare Limited has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy essential indicators, Metropolis Healthcare is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors. ...more
Payout Ratio 0.139 | Ex Dividend Date 2023-11-17 |
1 | Metropolis Healthcare - Asian Paints, Britannia among 5 stocks with short covering - The Economic Times | 11/19/2024 |
| Begin Period Cash Flow | 688.3 M |
Metropolis |
Metropolis Healthcare Relative Risk vs. Return Landscape
If you would invest 210,000 in Metropolis Healthcare Limited on August 25, 2024 and sell it today you would lose (3,815) from holding Metropolis Healthcare Limited or give up 1.82% of portfolio value over 90 days. Metropolis Healthcare Limited is generating negative expected returns and assumes 1.6375% volatility on return distribution over the 90 days horizon. Simply put, 14% of stocks are less volatile than Metropolis, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Metropolis Healthcare Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Metropolis Healthcare's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Metropolis Healthcare Limited, and traders can use it to determine the average amount a Metropolis Healthcare's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0099
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | METROPOLIS |
Estimated Market Risk
| 1.64 actual daily | 14 86% of assets are more volatile |
Expected Return
| -0.02 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Metropolis Healthcare is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Metropolis Healthcare by adding Metropolis Healthcare to a well-diversified portfolio.
Metropolis Healthcare Fundamentals Growth
Metropolis Stock prices reflect investors' perceptions of the future prospects and financial health of Metropolis Healthcare, and Metropolis Healthcare fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Metropolis Stock performance.
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.0863 | ||||
| Profit Margin | 0.12 % | ||||
| Operating Margin | 0.18 % | ||||
| Current Valuation | 103.35 B | ||||
| Shares Outstanding | 51.27 M | ||||
| Price To Book | 8.73 X | ||||
| Price To Sales | 8.07 X | ||||
| Revenue | 12.08 B | ||||
| Gross Profit | 9.1 B | ||||
| EBITDA | 2.97 B | ||||
| Net Income | 1.28 B | ||||
| Cash And Equivalents | 198.82 M | ||||
| Total Debt | 1.97 B | ||||
| Book Value Per Share | 231.09 X | ||||
| Cash Flow From Operations | 2.64 B | ||||
| Earnings Per Share | 28.69 X | ||||
| Total Asset | 15.55 B | ||||
| Retained Earnings | 9.17 B | ||||
About Metropolis Healthcare Performance
By examining Metropolis Healthcare's fundamental ratios, stakeholders can obtain critical insights into Metropolis Healthcare's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Metropolis Healthcare is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Metropolis Healthcare is entity of India. It is traded as Stock on NSE exchange.Things to note about Metropolis Healthcare performance evaluation
Checking the ongoing alerts about Metropolis Healthcare for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Metropolis Healthcare help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Metropolis Healthcare generated a negative expected return over the last 90 days | |
| About 44.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Metropolis Healthcare - Asian Paints, Britannia among 5 stocks with short covering - The Economic Times |
- Analyzing Metropolis Healthcare's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Metropolis Healthcare's stock is overvalued or undervalued compared to its peers.
- Examining Metropolis Healthcare's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Metropolis Healthcare's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Metropolis Healthcare's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Metropolis Healthcare's stock. These opinions can provide insight into Metropolis Healthcare's potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Metropolis Stock
Metropolis Healthcare financial ratios help investors to determine whether Metropolis Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Metropolis with respect to the benefits of owning Metropolis Healthcare security.